Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
The world is dealing with a global pandemic of severe acute respiratory coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19), which is the illness caused by SARS-CoV-2, is overwhelming healthcare systems around the world. Although the main clinical manifestations of COVID-19 are respirato...
        Saved in:
      
    
          | Main Authors: | Mahmoud Abdelnabi, Nouran Eshak, Yehia Saleh, Abdallah Almaghraby | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Radcliffe Medical Media
    
        2020-06-01 | 
| Series: | European Cardiology Review | 
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2020.16 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?        
                          
 by: Mahmoud Abdelnabi, et al.
 Published: (2020-02-01)
- 
                
                    Ivabradine and AF: Coincidence, Correlation or a New Treatment?        
                          
 by: Mahmoud Abdelnabi, et al.
 Published: (2020-01-01)
- 
                
                    Coronavirus Disease 2019 and Catheterisation Laboratory Considerations: “Looking for Essentials”        
                          
 by: Syed Haseeb Raza Naqvi, et al.
 Published: (2020-07-01)
- 
                
                    A Study on Coronavirus Disease-2019 Stigma Associated with Coronavirus Disease-2019 Warriors and an Insight into Community Perception        
                          
 by: Madhavi GAJULA, et al.
 Published: (2022-03-01)
- 
                
                    Accumulation of endogenous Muse cells in the myocardium and its pathophysiological role in patients with fulminant myocarditis        
                          
 by: Shigeru Toyoda, et al.
 Published: (2024-11-01)
 
       